SpaceX Earnings Preview: Bernstein Says 4 Key Factors Will Drive Long-Term Valuation 
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says 
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges 
Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth 
Tesla Weighs China Business Separation Amid SpaceX Merger Speculation 
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand 
Same sparkle, different story: how lab-grown diamonds are transforming the market 
Capital One Says AML Review Led to Closure of Trump Organization Accounts 
Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer 
Anthropic Reveals Claude AI Accessed Real Production Systems During Cybersecurity Tests 
Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness 
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race 
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight 
Chery Invests $75 Million in KG Mobility to Expand Global Automotive Partnership 
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners 
Meta Cuts Wipro Outsourcing by 25% After AI-Led Restructuring 
Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring 
SAN CLEMENTE, Calif., April 12, 2018 -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced the time of its first quarter 2018 earnings release and conference call.
The Company will release its first quarter 2018 results on Wednesday, May 9th, 2018 at approximately 4:00 p.m. EST (1:00 p.m. PST) and will be conducting a conference call concerning those results at 4:30 p.m. EST (1:30 p.m. PST) on Wednesday, May 9th, 2018. The call can be accessed at (800) 936-9761, conference ID 3029969. The conference call will be simultaneously available by webcast, which can be accessed by going to the Company's website at www.icumed.com, clicking on the Investors tab, clicking on the Webcast icon and following the prompts. The webcast will also be available by replay.
About ICU Medical, Inc.
ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells innovative medical devices used in vascular therapy, and critical care applications. ICU Medical's product portfolio includes IV smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical, Inc. can be found at www.icumed.com.
CONTACT:
ICU Medical, Inc.
Scott Lamb, Chief Financial Officer
(949) 366-4227
ICR, Inc.
John Mills, Partner
(646) 277-1254
